Targeting Huntingtin in Patients with Huntington's Disease. Reply
N Engl J Med
.
2019 Sep 19;381(12):1181-1182.
doi: 10.1056/NEJMc1910544.
Authors
Sarah J Tabrizi
1
,
Anne V Smith
2
,
C Frank Bennett
2
Affiliations
1
University College London, London, United Kingdom
[email protected]
.
2
Ionis Pharmaceuticals, Carlsbad, CA.
PMID:
31532970
DOI:
10.1056/NEJMc1910544
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Huntingtin Protein
Huntington Disease*
Nerve Tissue Proteins
Nuclear Proteins
Substances
Huntingtin Protein
Nerve Tissue Proteins
Nuclear Proteins
Grants and funding
200181/Z/15/Z/WT_/Wellcome Trust/United Kingdom